Tag: Equities

...
Drug-Pricing Reform an Uphill Battle

The Biden administration’s highly anticipated plan for drug-pricing reform includes...

View
...
Taiwan Shines in the Golden Era of IC Design

As it becomes increasingly difficult to make smaller transistors, chip...

View
...
A Greener, Net-Zero Future for Aviation?

The pandemic has forced a reset for the global aviation...

View
...
Sustainable Investing – The Defining Decades

A lot can happen in 30 years. Over the past...

View
...
An Uneasy Truce

IN THIS ISSUE As investors grow accustomed to continued strong...

View
...
Japan Steps Up as Suga Steps Down

Japanese equities have staged a strong turnaround of 11.2%1, fuelled...

View
...
Vietnam’s Financial Markets to Power On

Vietnam is increasingly becoming an attractive destination for investors encouraged...

View
...
Institutional Investor Highlights Leadership in European Equity Research

Exane BNP Paribas maintains its position as number 1 research...

View
...
Vescore Global Market Outlook September 2021

In the latest Global Market Outlook, our specialist team for...

View
...
Pandemic Guerilla

Key points   Even if it may be a “blip”...

View

Disclaimer: Professional Investors Only

 

This website is intended exclusively for professional investors as defined under applicable laws and regulations. It is not designed for retail investors or members of the general public.

 

By accessing this site, you acknowledge and agree to the following terms:

 

The content provided is strictly for informational purposes and does not constitute financial, investment, legal, or tax advice.


Any investment decisions based on the information contained herein are made at your own discretion and risk.

 

The operators of this website are not responsible for any losses or damages resulting from reliance on the provided information.


If you do not qualify as a professional investor, please refrain from accessing this website and exit immediately.